SHL Siemens Healthineers AG
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers magnetic resonance imaging, computed tomography, X-ray, molecular imaging, and ultrasound systems; and software solutions to support the reading and structured reporting of diagnostic images from different modalities. Its Diagnostics segment provides in-vitro diagnostic products and services to healthcare providers in the fields of general and specialty laboratory, and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment offers microwave, cryoablation, and embolization technologies, as well as clinical professional services for cancer care that support oncology departments in hospitals and clinics; and customized support for cancer care operations. Its Advanced Therapies segment provides products that are designed to support image-guided minimally invasive clinical procedures in various areas, such as cardiology, neurology, and oncology; angiography systems and mobile C-arms; and AI-powered clinical applications. It also offers essential technical customer service, such as maintenance and repair; spare parts; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as healthcare consulting, products, and services. It has strategic partnership with IFS and Novo. The company was founded in 1896 and is headquartered in Forchheim, Germany. Siemens Healthineers AG is a subsidiary of Siemens Aktiengesellschaft.…
Industry Peers
Medical DevicesKey Statistics
About Siemens Healthineers (ETR: SHL)
›
Siemens Healthineers (ETR: SHL) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 74,600 employees.
The shares were at 43.82 EUR on 19 November 2026, down 4.8% over 52 weeks. Its 52-week range is 32.81 EUR to 49.71 EUR: the price is 11.8% below the high and 33.6% above the low.
At a market capitalisation of 49.04B EUR, it trades at 22.2 times trailing earnings and 16.7 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.6, a discount of 13% for SHL. It pays a dividend yielding 2.31% (it pays out 51% of its earnings), against a median of 2.41% among the dividend payers in that peer group.
Siemens Healthineers reports return on equity of 11.2%, an operating margin of 13.5% and revenue up 7.3% year over year.
Its debt exceeds its cash by 12.20B EUR, a debt-to-equity ratio of 0.04. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 20 analysts cover the stock, with an average rating of Buy; their mean price target of 46.74 EUR is 6.7% above the current price. The next earnings report is expected on 4 February 2027.